ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Mayo Clinic at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Mayo Clinic takes part in 20 sessions at ESMO 2026 in Madrid. Its program covers treatment outcomes and care across several cancers, including neuroendocrine tumours and lung cancer. Specific topics include radioligand therapy for neuroendocrine tumours and real-world comparisons of treatments for cancers that have spread to bone.

OrganizationESMO 2026 Attendance
Mayo Clinic
Rochester, MN
Cancer centre & hospital
Nonprofit academic medical centre in Rochester, Minnesota, with an NCI-designated comprehensive cancer centre.
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Chair
Fri Oct 23
13:30–15:00
Rapid oral: CNS tumours
with Maastricht UMC+, Pitié-Salpêtrière Hospital
Sarcoma, CNS, head & neck and rare cancers
Abstract
Fri Oct 23
13:45–13:57
Invited Discussant 695RO, 696RO and 697RO
Rapid oral: CNS tumours
Sarcoma, CNS, head & neck and rare cancers
Poster
Fri Oct 23
15:15–16:00
Hypogammaglobulinaemia and infectious hospitalisation in patients with solid tumours: A retrospective cohort study
Friday Poster Display session 3
Nursing & supportive care
Poster
Fri Oct 23
15:15–16:00
Poster
Fri Oct 23
15:15–16:00
Abstract
Fri Oct 23
16:25–16:30
Chair
Sat Oct 24
10:15–11:45
Theranostics: A magic bullet story from theory to clinics
with LMU Munich
Sarcoma, CNS, head & neck and rare cancers
Poster
Sun Oct 25
12:00–12:45
Poster
Sun Oct 25
12:00–12:45
Chair
Sun Oct 25
14:45–16:15
Radioligand therapy: A game-changer in the treatment sequence of advanced neuroendocrine tumors
with University Hospital Erlangen
Sarcoma, CNS, head & neck and rare cancers
Talk
Sun Oct 25
15:45–16:05
Looking ahead: Next frontiers of radioligands in neuroendocrine neoplasms
Radioligand therapy: A game-changer in the treatment sequence of advanced neuroendocrine tumors
Sarcoma, CNS, head & neck and rare cancers
Poster
Mon Oct 26
12:00–12:45
Clinical outcomes with trastuzumab deruxtecan in ovarian cancer: A real-world multicenter experience
Monday Poster Display session 1
Gynaecological cancers
Poster
Mon Oct 26
12:00–12:45
Poster
Mon Oct 26
12:00–12:45
Predicting immunotherapy and platinum therapy response in extrapulmonary neuroendocrine carcinomas by tumor microenvironment transcriptomics
Monday Poster Display session 3
Gastrointestinal cancersSarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology
Poster
Mon Oct 26
12:00–12:45
Real-world management of extrapulmonary neuroendocrine carcinoma (epNEC) from the perspective of healthcare providers in the VOICE study
Monday Poster Display session 3
Gastrointestinal cancersSarcoma, CNS, head & neck and rare cancers
Poster
Mon Oct 26
12:00–12:45
Real-world outcomes of trastuzumab deruxtecan (T-DXd) in patients with advanced gynecologic malignancies
Monday Poster Display session 1
Gynaecological cancers
Satellite
Mon Oct 26
18:45–19:15
Understanding the patient’s experience with RPT
Lumara Bio, a division of ITM - What every Oncologist needs to know about Theranostics · with University Hospital Essen, Huntsman Cancer Institute, European Institute of Oncology (IEO)
Satellite
Mon Oct 26
19:15–19:25
Unlocking the full potential of RPT in future developments
Lumara Bio, a division of ITM - What every Oncologist needs to know about Theranostics · with University Hospital Essen, Huntsman Cancer Institute, European Institute of Oncology (IEO)
Satellite
Mon Oct 26
19:25–19:40
Audience Q&A
Lumara Bio, a division of ITM - What every Oncologist needs to know about Theranostics · with University Hospital Essen, Huntsman Cancer Institute, European Institute of Oncology (IEO)

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Mayo Clinic

Tell us what you sell and we’ll find the people at Mayo Clinic most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction